Company Filing History:
Years Active: 2007
Mokdad Mezna: Innovating Monitoring Methods with Cyclacel Limited
Leeds, GB - Meet Mokdad Mezna, an innovative inventor and researcher from Cyclacel Limited. With a passion for developing groundbreaking methods, Mokdad has revolutionized the way we analyze polypeptides in a sample. Through his patent titled "Compositions and Methods for Monitoring the Modification State of a Pair of Polypeptides," Mokdad presents a novel approach to monitor and assess the modification state of immobilized polypeptides.
His invention focuses on a method that involves several key steps. The first step consists of immobilizing a polypeptide to a physical support, creating a stable foundation for further analysis. The following step involves contacting the immobilized polypeptide with a test sample, potentially containing an agent capable of modifying the immobilized polypeptide. By doing so, Mokdad's method allows researchers to observe the effects of various agents on the polypeptide of interest.
The third step in the process is critical and involves contacting the immobilized polypeptide with a binding partner polypeptide. The binding of this partner polypeptide to the immobilized polypeptide is dependent on the modification state of the latter. By observing the association of the binding partner polypeptide, researchers can infer important information about the modification state of the immobilized polypeptide.
Lastly, Mokdad's method includes the measurement of the association between the binding partner polypeptide and the immobilized polypeptide. This step provides valuable quantitative data that allows researchers to further analyze and understand the modification state of the polypeptide.
Mokdad Mezna's work at Cyclacel Limited has undoubtedly made significant contributions to the field of polypeptide analysis. His patent showcases a method that enables researchers to gain valuable insights into the modification state of polypeptides, providing a foundation for further research and development in various biomedical and biochemical applications.
Supported by his talented coworkers, such as John Colyer and Roger Kingdon Craig, Mokdad's innovative approach to polypeptide analysis demonstrates the commitment to advancements that Cyclacel Limited stands for. With their dedication to pioneering methods and technologies, Cyclacel Limited has become a reputable company at the forefront of scientific innovation.
In conclusion, Mokdad Mezna's patent on compositions and methods for monitoring the modification state of polypeptides is a remarkable contribution to the field. His work, in collaboration with the talented team at Cyclacel Limited, showcases the importance of groundbreaking inventions and their potential impact on the scientific community.